000 02178nam  2200361zi 4500
0019.940346
003CaOODSP
00520240731105755
006m     o  d f      
007cr |n|||||||||
008240709e200603  oncd    o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
041 |aeng|bfre
043 |an-cn---
0861 |aH14-637/2006E-PDF
24500|a2006 general public opinion survey on key issues pertaining to post-market surveillance of marketed health products in Canada : |bfinal report / |cprepared for Health Canada [by] Decima Research.
264 1|a[Ottawa] : |b[Health Canada], |cMarch 2006.
300 |a1 online resource (40, 32 pages) : |bcolour charts + |eexecutive summary (4 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Sondage d’opinion publique sur les principaux enjeux relatifs à la surveillance des produits de santé commercialisés au Canada (2006) : rapport final.
500 |a"HCPOR-05-94."
500 |a"Contract #: H1011-050073/001/CY."
520 |a"This report presents the results of a national survey examining public opinion on the safety of marketed health products in Canada. The research aimed to understand Canadians’ awareness and information use pertaining to the safety of health products, and to identify the most commonly-used sources of this information"--Executive summary, page 3.
546 |aIncludes some text in French.
650 0|aHealth products|xSafety measures|zCanada|xPublic opinion.
650 0|aPublic opinion|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
7102 |aDecima Research, |econsultant.
77508|tSondage d’opinion publique sur les principaux enjeux relatifs à la surveillance des produits de santé commercialisés au Canada (2006) : |w(CaOODSP)9.941210
85640|qPDF|s560 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-637-2006-eng.pdf|zFinal report
85640|qPDF|s33 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-637-2006-1-eng.pdf|zExecutive summary